We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00400894
Recruitment Status : Unknown
Verified February 2007 by ProteoSys AG.
Recruitment status was:  Active, not recruiting
First Posted : November 17, 2006
Last Update Posted : February 5, 2007
Charite University, Berlin, Germany
University Hospital Tuebingen
Medical Centre, Ludwigshafen, Germany
Medical University Innsbruck
Information provided by:
ProteoSys AG

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : September 2006